EPHB6
Ephrin type-B receptor 6
Also known as: EPHB6_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- O15197
- Gene
- EPHB6
- Canonical length
- 1021 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for EPHB6 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
1021 residues, UniProt reviewed canonical sequence.
>O15197|EPHB6
1 MATEGAAQLG NRVAGMVCSL WVLLLVSSVL ALEEVLLDTT GETSEIGWLT YPPGGWDEVS
61 VLDDQRRLTR TFEACHVAGA PPGTGQDNWL QTHFVERRGA QRAHIRLHFS VRACSSLGVS
121 GGTCRETFTL YYRQAEEPDS PDSVSSWHLK RWTKVDTIAA DESFPSSSSS SSSSSSAAWA
181 VGPHGAGQRA GLQLNVKERS FGPLTQRGFY VAFQDTGACL ALVAVRLFSY TCPAVLRSFA
241 SFPETQASGA GGASLVAAVG TCVAHAEPEE DGVGGQAGGS PPRLHCNGEG KWMVAVGGCR
301 CQPGYQPARG DKACQACPRG LYKSSAGNAP CSPCPARSHA PNPAAPVCPC LEGFYRASSD
361 PPEAPCTGPP SAPQELWFEV QGSALMLHWR LPRELGGRGD LLFNVVCKEC EGRQEPASGG
421 GGTCHRCRDE VHFDPRQRGL TESRVLVGGL RAHVPYILEV QAVNGVSELS PDPPQAAAIN
481 VSTSHEVPSA VPVVHQVSRA SNSITVSWPQ PDQTNGNILD YQLRYYDQAE DESHSFTLTS
541 ETNTATVTQL SPGHIYGFQV RARTAAGHGP YGGKVYFQTL PQGELSSQLP ERLSLVIGSI
601 LGALAFLLLA AITVLAVVFQ RKRRGTGYTE QLQQYSSPGL GVKYYIDPST YEDPCQAIRE
661 LAREVDPAYI KIEEVIGTGS FGEVRQGRLQ PRGRREQTVA IQALWAGGAE SLQMTFLGRA
721 AVLGQFQHPN ILRLEGVVTK SRPLMVLTEF MELGPLDSFL RQREGQFSSL QLVAMQRGVA
781 AAMQYLSSFA FVHRSLSAHS VLVNSHLVCK VARLGHSPQG PSCLLRWAAP EVIAHGKHTT
841 SSDVWSFGIL MWEVMSYGER PYWDMSEQEV LNAIEQEFRL PPPPGCPPGL HLLMLDTWQK
901 DRARRPHFDQ LVAAFDKMIR KPDTLQAGGD PGERPSQALL TPVALDFPCL DSPQAWLSAI
961 GLECYQDNFS KFGLCTFSDV AQLSLEDLPA LGITLAGHQK KLLHHIQLLQ QHLRQQGSVE
1021 VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPHB6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 80 nTPM
Expression across tissuesHPA
Tissue
- skin: 80 nTPM
- cerebral cortex: 70 nTPM
- basal ganglia: 42 nTPM
- cervix: 24 nTPM
- vagina: 22 nTPM
- prostate: 17 nTPM
Single-cell type
- müller glia: 137 nCPM
- suprabasal keratinocytes: 82 nCPM
- mesothelial cells: 61 nCPM
- prostatic glandular cells: 57 nCPM
- brain inhibitory neurons: 52 nCPM
- basal keratinocytes: 44 nCPM
Immune cell
- memory B-cell: 1.6 nTPM
- naive CD4 T-cell: 1.4 nTPM
- memory CD4 T-cell: 1.1 nTPM
- T-reg: 1 nTPM
- classical monocyte: 0.8 nTPM
- naive CD8 T-cell: 0.7 nTPM
Brain region
- cerebral cortex: 120 nTPM
- white matter: 83 nTPM
- basal ganglia: 71 nTPM
- amygdala: 21 nTPM
- thalamus: 18 nTPM
- hippocampal formation: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.98
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- ephrin receptor activity
- signaling receptor activity
- transmembrane-ephrin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Ephrin, ligand binding domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Tyrosine-protein kinase, receptor class V, conserved site
- Sterile alpha motif domain
- Fibronectin type III
- Galactose-binding-like domain superfamily
- Growth factor receptor cysteine-rich domain superfamily
- Protein kinase-like domain superfamily
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Sterile alpha motif/pointed domain superfamily
- Immunoglobulin-like fold
- Ephrin receptor type-A /type-B
- Ephrin, transmembrane domain
- Fibronectin type III superfamily
- Ephrin receptor tyrosine kinases
- Fibronectin type III domain
- Ephrin receptor ligand binding domain
- SAM domain (Sterile alpha motif)
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Protein tyrosine and serine/threonine kinase
- Ephrin type-A receptor 2 transmembrane domain
- Ephrin cysteine rich domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EPHB6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPHB6 as an antibody target. Whether an autoantibody or antibody against EPHB6 could matter depends on whether native EPHB6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPHB6 is annotated as secreted, so native EPHB6 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label EPHB6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...